Education
About Us
Working with TipRanks
Follow Us
Pak Fah Yeow International Limited (HK:0239)
:0239
RESEARCH TOOLSreports
0239 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$2.11 - HK$2.65
Previous CloseN/A
Volume52.50K
Average Volume (3M)43.73K
Market Cap
HK$793.12M
Enterprise ValueHK$507.49M
Total Cash (Recent Filing)HK$290.02M
Total Debt (Recent Filing)HK$4.20M
Price to Earnings (P/E)10.1
Beta-0.07
Next Earnings
Aug 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 07, 2025Dividend Yield14.93%
Share Statistics
EPS (TTM)0.25
Shares Outstanding311,640,000
10 Day Avg. Volume14,750
30 Day Avg. Volume43,733
Financial Highlights & Ratios
PEG Ratio-0.51
Price to Book (P/B)1.06
Price to Sales (P/S)0.00
P/FCF Ratio8.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pak Fah Yeow International Limited News
PremiumCompany Announcements
Pak Fah Yeow International Limited Updates Nomination Committee Terms
PremiumCompany Announcements
Pak Fah Yeow International Limited Announces Successful AGM Resolutions
PremiumCompany Announcements
Pak Fah Yeow International Limited Announces AGM and Share Repurchase Plan
PremiumCompany Announcements
Pak Fah Yeow Reports Decline in 2024 Profits Amid Healthcare Sales Slump
PremiumCompany Announcements
Pak Fah Yeow Announces Final and Special Dividends for 2024PremiumCompany Announcements
Pak Fah Yeow Declares Final Dividend for 20240239 FAQ
What was Pak Fah Yeow International Limited’s price range in the past 12 months?
Pak Fah Yeow International Limited lowest stock price was HK$2.11 and its highest was HK$2.65 in the past 12 months.
What is Pak Fah Yeow International Limited’s market cap?
Pak Fah Yeow International Limited’s market cap is HK$793.12M.
When is Pak Fah Yeow International Limited’s upcoming earnings report date?
Pak Fah Yeow International Limited’s upcoming earnings report date is Aug 27, 2025 which is in 48 days.
How were Pak Fah Yeow International Limited’s earnings last quarter?
Pak Fah Yeow International Limited released its earnings results on Mar 27, 2025. The company reported HK$0.1 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.1.
Is Pak Fah Yeow International Limited overvalued?
According to Wall Street analysts Pak Fah Yeow International Limited’s price is currently Overvalued.
Does Pak Fah Yeow International Limited pay dividends?
Pak Fah Yeow International Limited pays a Notavailable dividend of HK$0.105 which represents an annual dividend yield of 14.93%. See more information on Pak Fah Yeow International Limited dividends here
What is Pak Fah Yeow International Limited’s EPS estimate?
Pak Fah Yeow International Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pak Fah Yeow International Limited have?
Pak Fah Yeow International Limited has 311,640,000 shares outstanding.
What happened to Pak Fah Yeow International Limited’s price movement after its last earnings report?
Pak Fah Yeow International Limited reported an EPS of HK$0.1 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pak Fah Yeow International Limited?
Currently, no hedge funds are holding shares in HK:0239
Pak Fah Yeow International Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.02%
12-Months-Change
Fundamentals
Return on Equity
10.50%
Trailing 12-Months
Asset Growth
-7.06%
Trailing 12-Months
Company Description
Pak Fah Yeow International Limited
Pak Fah Yeow International Limited, together with its subsidiaries, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People's Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and internationally. It operates through three segments: Healthcare, Property Investments, and Treasury Investments. The company offers white flower embrocation medicated oils, strain relief products, and ointments under, as well as Fúzai 239, a floral-scented white flower embrocation. In addition, it invests in commercial, industrial, residential, and car park properties; and provides advertising agency services. The company was founded in 1927 and is headquartered in Wan Chai, Hong Kong.
Technical Analysis
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H
―
Wai Yuen Tong Medicine Holdings Limited
―
PuraPharm Corp. Ltd.
―
Fusen Pharmaceutical Co., Ltd.
―
Zhongzhi Pharmaceutical Holdings Limited
―